HOME >> BIOLOGY >> NEWS
$6.5M nanomedicine center includes Yale engineer

New Haven, Conn. --A Yale scientist is among the recipients of a special $6.5 million center grant from the National Eye Institute of the National Institutes of Health, intended to rapidly launch revolutionary ideas in the use of nanomedicine and serve as the centerpiece of its Nanomedicine Roadmap Initiative.

David A. LaVan, an assistant professor of mechanical engineering and member of Yale's Interdisciplinary Neuroscience Program, will participate in the National Center for Design of Biomimetic Nanoconductors, one of the four centers funded. The center will be led by Professor Eric G. Jakobsson at the University of Illinois Urbana-Champaign.

The five-year grant will support a multidisciplinary and multi-institutional project to design, model, synthesize and fabricate nanomedical devices based on natural and synthetic ion transporters, proteins that control ion motion across the membrane of every living cell. Nanomedicine operates at the biological molecule scale of 100 nanometers or less to cure disease or repair damaged tissues. A nanometer is one-billionth of a meter.

The first target for the center will be to design a class of devices for generating electric power --biobatteries -- for a wide array of implantable devices, including an artificial retina. LaVan, who was recently awarded a grant from the Keck Foundation to develop novel materials to convert sunlight into electricity, will oversee design of the biobattery for the Center.

"This focus is intended to leverage our significant understanding of ion transport at the molecular level," said LaVan, who chaired a group at the 2004 National Academies Keck Futures Conference, Designing Nanostructures, where aspects of this project were formulated. "We are set to develop revolutionary new devices to treat disease and to develop implantable devices that mimic natural functions."

The team expects to construct several categories of devices including sensors, power source
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
14-Oct-2005


Page: 1 2

Related biology news :

1. Barcelona University, ESF to host nanomedicine conferences
2. $16 million grant advances nanomedicine at Washington University
3. Multicenter study nets new lung tumor-suppressor gene
4. Brains hearing center may reorganize after implant of cochlear device
5. UC Davis is partner in new $125 million federal bioenergy research center
6. ORNL-led team wins DOE bioenergy center
7. Research center unites biomedical competitors to fund medical technology development
8. Fibers are center stage at international conference
9. 3M Manchester research center to develop vital new science
10. UC Davis wins new national center for avian flu research
11. University and health science center in San Antonio collaborate to find chlamydia vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: nanomedicine center includes Yale engineer

(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... own microbial terroir, meaning the microbial populations found on ... product, creating the final flavor according to research published ... Environmental Microbiology . This is the first time investigators ... , Many sake makers inoculate with both bacteria ... the University of California, Davis, but he and his ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4The microbes make the sake brewery 2
(Date:7/24/2014)... to settle into equilibriuma state of unchanging balance ... of non-equilibrium conditions where new possibilities lie. Non-equilibrium ... such as temperature fluctuations, freezing and melting, or ... body temperature, airplanes to fly, and the Earth ... even though these conditions exist naturally and are ...
(Date:7/24/2014)... Research and Markets has announced ... Analytical Instruments Market 2014-2018" report to their offering. ... Genomics is the study of the gene and its ... and functions of proteomes or sets of proteins by ... involves the mapping of genes and DNA sequencing to ...
(Date:7/24/2014)... 2014 SRI International has been awarded a ... of Allergy and Infectious Diseases (NIAID), part of the ... potential therapies for HIV infection and AIDS. The contract ... AIDS and the complications and opportunistic infections associated with ... transmission of HIV. According to the ...
(Date:7/24/2014)... 2014 Three companies from the angelMD ... Big C Competition. Out of 700 competition entrants, Chiron ... the semi-final round. In this round twenty teams are ... complete with mentoring from thought-leaders and medical entrepreneurs from ... the angelMD commitment to the Livestrong vision around the ...
Breaking Biology Technology:New approach to form non-equilibrium structures 2Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 33 angelMD Startups Make Livestrong Big C Semi-finals 2
Cached News: